调强放疗条件下鼻咽癌原发肿瘤体积对预后的影响

doi:10.3760/cma.j.issn.1004-4221.2012.03.004

摘要
图/表
参考文献()
相关文章 (15)
点击分布统计
下载分布统计

全文: PDF (0 KB) HTML (1 KB)
输出: BibTeX | EndNote (RIS) 背景资料

摘要

目的探讨调强放疗条件下鼻咽癌原发肿瘤体积(PTV)对患者预后的影响。方法 330例接受调强放疗的鼻咽癌初治患者入组本研究。所有患者治疗前均行CT增强扫描,扫描图像资料输人三维治疗计划系统进行肿瘤轮廓勾画和PTV计算。在国际抗癌联盟2002年T分期框架内借助受试者工作特征曲线,将所有患者按PTV大小分为V₁(<10 cm³)、V₂(10~ 25 cm³)、V₃(>25~50 cm³)、V₄(>50 cm³)组。用 Kaplan Meier 法计算生存率并 Logrank 检验, Cox 回归模型分析原发肿瘤体积与患者预后的关系。结果随访率100%。330例鼻咽癌患者所测平均PTV为(34.2±27.1) cm³(0.4~153.7 cm³)。V₁、V₂、V₃、V₄组 3年总生存率分别为88.6%、90.0%、91.2%、74.2%(χ²=12.83, P=0.005)。PTV>50 cm³ (V₄组)和≤50 cm³(V₁+V₂+V₃) 者 3年无远处转移生存率和无瘤生存率及总生存率均明显下降 [77.4%∶89.9%(χ²=7.24, P=0.007)和64.5%∶85.1%(χ²=13.95, P=0.000) 及74.2%∶90.3% (χ²=11.76, P=0.001)]。多因素分析证实PTV同N分期一样,是影响患者生存的预后因素(χ²=0.00, P=2.580)。结论鼻咽癌PTV可能是影响患者生存的一个重要的预后因素。

	服务

	把本文推荐给朋友
	加入我的书架
	加入引用管理器
	E-mail Alert
	RSS
	作者相关文章
	陈传本
	潘建基
	陈荔莎
	柏朋刚
	林少俊
	张瑜
	张秀春
	费召东

关键词 ：鼻咽肿瘤/调强放射疗法, 计划靶体积, 预后

Abstract：

Objective To analyze the correlation between primary tumor volume (PTV) and prognosis of nasopharyngeal carcinoma (NPC) treated by intensity-modulated radiotherapy (IMRT). Methods 330 NPC patients treated by IMRT were included. Pretreatment computerized tomography image were input into tree-dimensional treatment-planning system, in which the primary tumor volume were calculated automatically. The receiver operating characteristic curve was used to determine the best cut-off point of PTV. Within the framework of UICC 2002 T stage,The PTV　was divided into four groups:V₁<10 cm³, V₂ 10－25 cm³, V₃>25－50 cm³ and V₄>50 cm³. Kaplan-Meier and Logrank test was used to analyze the survival, Cox proportion risk regression model were used to analysis the correlation between PTV and prognosis. Results The mean PTV for all NPC patients was (34.2±27.1) cm³ with the range of 0.4－153.7 cm³. The 3-year overall survival for V₁, V₂, V₃ and V₄ stage were 88.6%,90.0%,91.2% and 74.2%, respectively (χ²=12.83,P=0.005). There was no significant difference among V₁, V₂ and V₃ in terms of overall survival (χ²=1.96,P=0.376). The 3-year distant metastasis-free survival and diseases-free survival or overall survival were decrease in PTV>50 cm³ and PTV≤50 cm³(77.4%∶89.9%, χ²=7.24, P=0.007and 64.5%∶85.1%, χ²=13.95,P=0.000 or 74.2%∶90.3%, χ²=11.76,P=0.001). Multivariate analysis revealed that PTV was a adverse prognostic factors for overall survival (χ²=0.00,P=2.580). Conclusion Our data showed that the primary tumor volume had significantly impacted on the prognosis of NPC patients treated by intensity modulated radiotherapy.

Key words： Nasopharyngeal neoplasms/intensity-modulated radiotherapy Planning target volume Prognosis

收稿日期: 2011-09-02

基金资助:

福建省自然科技基金项目(2010J01137)

引用本文:

陈传本,潘建基,陈荔莎等. 调强放疗条件下鼻咽癌原发肿瘤体积对预后的影响[J]. 中华放射肿瘤学杂志, 2012, 21(3): 205-208.

CHEN Chuan-ben^*,PAN Jian-ji,CHEN Li-sha et al. Significance of primary tumor volume on prognosis in nasopharyngeal carcinoma treated by intensity-modulated radiotherapy[J]. Chinese Journal of Radiation Oncology, 2012, 21(3): 205-208.

链接本文:

http://journal12.magtechjournal.com/Jweb_fszlx/CN/10.3760/cma.j.issn.1004-4221.2012.03.004 或 http://journal12.magtechjournal.com/Jweb_fszlx/CN/Y2012/V21/I3/205

[1] Mukherji SK, Schmalfuss IM, Casteligns J, et al. Clinical applications of tumor volume measurements for predicting outcome in patients with squamous cell carcinoma of the upper aerodigestive tract. Am J Neuroradiol,2004,25:1425-1432.
[2] Chen SW, Yang SN, Liang JA, et al. Value of computed tomography-based tumor volume as a predictor of outcomes in hypopharyngeal cancer after treatment with definitive radiotherapy. Laryngoscope,2006,116:2012-2017.
[3] Shen C, Lu J, Gu Y, et al. Prognostic impact of primary tumorvolume in patients with nasopharyngeal carcinoma treated by

definitive radiation therapy. Laryngoscope,2008,118:1206-1210.
[4] Lee CC, Chu ST, Ho HC, et al. Primary tumor volume calculation as a predictive factor of prognosis in nasopharyngeal carcinoma. Acta Oto-Laryngologica,2008,128:93-97.
[5] Chen Mk, Chen TH, Liu JP, et al. Better prediction of prognosis for patients with nasopharyngeal carcinoma using primary tumor volume. Cancer,2004,100:2160-2166.
[6] Chen C, Fei Z, Pan J, et al. Significance of primary tumor volume and T-stage on prognosis in nasopharyngeal carcinoma treated with intensity-modulated radiation therapy. Jpn J Clin Oncol,2011,41:537-542.
[7] Gospodarowicz MK, Miller D, Groome PA, et al. The process for continuous improvement of the TNM classification. Cancer,2004,100:1-5.
[8] 中国鼻咽癌临床分期工作委员会. 鼻咽癌′92分期修订工作报告.中华放射肿瘤学杂志,2009,18:2-6.
[9] American joint committee on cancer. AJCC cancer staging handbook from the AJCC cancer staging manual.7th ed. New York:Springer,2009.
[10] Zhou JY, Chong VF, Khoo JB, et al. The relationship between nasopharyngeal carcinoma tumor volume and TNM T-classification:a quantitative analysis. Eur Arch Otorhinolaryngol,2007,264:169-174.
[11] Chu ST, Wu PH, Hou YY, et al. Primary tumor volume of nasopharyngeal carcinoma:significance for recurrence and survival. J Chin Med Assoc,2008,71:461-466.
[12] Willner J, Baier K, Pfreundner L, et al. Tumor volume and local control in primary radiotherapy of nasopharyngeal carcinoma. Acta Oncol,1999,38:1025-1030.
[13] Lin S, Pan J, Han L, et al. Nasopharyngeal carcinoma treated with reduced-volume intensity-modulated radiotherapy report on the 3-year outcome of a prospective series. Int J Radiat Oncol Biol Phys,2009,75:1071-1078．
[14] Lee CC, Huang TT, Lee MS, et al. Clinical application of tumor volume in advanced nasopharyngeal carcinoma to predict outcome. Radiat Oncol,2010,5:20.